RecruitingNot ApplicableNCT06099158

Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes

Sponsor

Tor Biering-Sørensen

Enrollment

1,428 participants

Start Date

May 31, 2024

Study Type

INTERVENTIONAL

Conditions

Heart Failure

Summary

The purpose of the study is to assess the impact of HeartLogic-guided management on clinical outcomes among patients implanted with an eligible cardiac device.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This Danish study is testing whether a smart monitoring system called HeartLogic — built into certain heart devices (ICDs and CRT-Ds) — can help doctors manage heart failure more effectively. The system tracks multiple body signals and alerts the care team when the patient's heart failure may be worsening, potentially allowing earlier intervention. **You may be eligible if...** - You already have an implanted heart device (ICD or CRT-D) that has the HeartLogic feature - You are 18 years or older - You are using remote monitoring and your data is being actively tracked **You may NOT be eligible if...** - There are no specific reasons listed that would exclude you (no formal exclusion criteria for this trial) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHeartLogic

HeartLogic alerts will be managed according to a standardized alert management guide to ensure uniform reactions to HeartLogic alerts.

Locations(1)

Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte

Hellerup, Capital Region, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06099158

Related Trials

HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management

NCT0740223915 locations

Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT06122779117 locations

CV Imaging of Metabolic Interventions

NCT056503071 location

Development of CIRC Technologies

NCT056542721 location

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

NCT070835571 location